Thu, January 19, 2023
Wed, January 18, 2023
Tue, January 17, 2023
Mon, January 16, 2023
Sat, January 14, 2023
Fri, January 13, 2023
Thu, January 12, 2023

Christopher Raymond Maintained (ABBV) at Buy with Increased Target to $157 on, Jan 17th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-increased-target-to-157-on-jan-17th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Christopher Raymond of Piper Sandler, Maintained "AbbVie Inc." (ABBV) at Buy with Increased Target from $155 to $157 on, Jan 17th, 2023.

Christopher has made no other calls on ABBV in the last 4 months.



There are 12 other peers that have a rating on ABBV. Out of the 12 peers that are also analyzing ABBV, 6 agree with Christopher's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Geoff Meacham of "B of A Securities" Maintained at Hold with Increased Target to $165 on, Wednesday, December 14th, 2022
  • Navaan Ty of "Exane BNP Paribas" Initiated at Hold and Held Target at $169 on, Thursday, December 8th, 2022
  • Justin Smith of "Societe Generale" Downgraded from Strong Buy to Hold on, Tuesday, November 8th, 2022
  • Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $155 on, Monday, October 31st, 2022
  • Navin Jacob of "UBS" Maintained at Hold with Increased Target to $147 on, Monday, October 31st, 2022
  • Steve Chesney of "Atlantic Equities" Maintained at Hold with Decreased Target to $157 on, Monday, October 31st, 2022


These are the ratings of the 6 analyists that currently disagree with Christopher


  • Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Increased Target to $180 on, Thursday, January 5th, 2023
  • Gavin Clark-Gartner of "Evercore ISI Group" Maintained at Buy with Decreased Target to $154 on, Tuesday, December 20th, 2022
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $182 on, Tuesday, December 6th, 2022
  • Trung Huynh of "Credit Suisse" Initiated at Buy and Held Target at $170 on, Friday, November 18th, 2022
  • Gary Nachman of "BMO Capital" Maintained at Buy with Decreased Target to $169 on, Monday, October 31st, 2022
  • David Risinger of "SVB Leerink" Maintained at Sell with Decreased Target to $135 on, Friday, September 30th, 2022

Publication Contributing Sources